+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Personalized Medicine"

miRNA Sequencing and Assays - Global Strategic Business Report - Product Thumbnail Image

miRNA Sequencing and Assays - Global Strategic Business Report

  • Report
  • September 2026
  • 465 Pages
  • Global
From
Tissue Microarrays - Global Strategic Business Report - Product Thumbnail Image

Tissue Microarrays - Global Strategic Business Report

  • Report
  • September 2026
  • 180 Pages
  • Global
From
Protein Microarrays - Global Strategic Business Report - Product Thumbnail Image

Protein Microarrays - Global Strategic Business Report

  • Report
  • September 2026
  • 186 Pages
  • Global
From
From
Cryopreservation Equipment - Global Strategic Business Report - Product Thumbnail Image

Cryopreservation Equipment - Global Strategic Business Report

  • Report
  • September 2026
  • 279 Pages
  • Global
From
DNA Microarrays - Global Strategic Business Report - Product Thumbnail Image

DNA Microarrays - Global Strategic Business Report

  • Report
  • September 2026
  • 234 Pages
  • Global
From
RNA and DNA Extraction Kit - Global Strategic Business Report - Product Thumbnail Image

RNA and DNA Extraction Kit - Global Strategic Business Report

  • Report
  • September 2026
  • 189 Pages
  • Global
From
Sequencing Reagents - Global Strategic Business Report - Product Thumbnail Image

Sequencing Reagents - Global Strategic Business Report

  • Report
  • September 2026
  • 428 Pages
  • Global
From
Live Cell Imaging - Global Strategic Business Report - Product Thumbnail Image

Live Cell Imaging - Global Strategic Business Report

  • Report
  • September 2026
  • 189 Pages
  • Global
From
Cell Therapy - Global Strategic Business Report - Product Thumbnail Image

Cell Therapy - Global Strategic Business Report

  • Report
  • September 2026
  • 263 Pages
  • Global
From
Antibody Library Technologies - Global Strategic Business Report - Product Thumbnail Image

Antibody Library Technologies - Global Strategic Business Report

  • Report
  • September 2026
  • 233 Pages
  • Global
From
Exosomes - Global Strategic Business Report - Product Thumbnail Image

Exosomes - Global Strategic Business Report

  • Report
  • September 2026
  • 212 Pages
  • Global
From
Human Platelet Lysate - Global Strategic Business Report - Product Thumbnail Image

Human Platelet Lysate - Global Strategic Business Report

  • Report
  • September 2026
  • 215 Pages
  • Global
From
From
From
Recombinant DNA Technology - Global Strategic Business Report - Product Thumbnail Image

Recombinant DNA Technology - Global Strategic Business Report

  • Report
  • September 2026
  • 212 Pages
  • Global
From
Single-Cell Genome Sequencing - Global Strategic Business Report - Product Thumbnail Image

Single-Cell Genome Sequencing - Global Strategic Business Report

  • Report
  • September 2026
  • 222 Pages
  • Global
From
Single Use Assemblies - Global Strategic Business Report - Product Thumbnail Image

Single Use Assemblies - Global Strategic Business Report

  • Report
  • September 2026
  • 390 Pages
  • Global
From
From
Tissue Sectioning - Global Strategic Business Report - Product Thumbnail Image

Tissue Sectioning - Global Strategic Business Report

  • Report
  • September 2026
  • 219 Pages
  • Global
From
Loading Indicator

Personalized Medicine is a form of biotechnology that focuses on tailoring medical treatments to the individual needs of a patient. It is based on the idea that each person's genetic makeup, lifestyle, and environment can affect their response to a particular treatment. This approach to medicine has the potential to improve patient outcomes and reduce healthcare costs. Personalized Medicine utilizes a variety of technologies, such as genomics, proteomics, and metabolomics, to identify and analyze a patient's unique characteristics. This information is then used to develop treatments that are tailored to the individual's needs. Additionally, personalized medicine can be used to identify and monitor diseases, predict drug responses, and develop new treatments. Some companies in the Personalized Medicine market include 23andMe, Illumina, and Thermo Fisher Scientific. Show Less Read more